Announcements
Takara Bio USA, Inc. (formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Takara, Clontech, and Cellartis brands. To keep you up to date with the latest happenings at Takara Bio USA, we have compiled our recent announcements and press releases below.
Takara Bio USA, Inc. launches rapid lentivirus test using smartphone app
Date: April 30, 2018
Categories: Press release
A leading biotechnology company has developed a rapid test to measure recombinant lentivirus titers using a smartphone as a diagnostic reader. Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) teamed up with smartphone diagnostics specialists, Novarum DX, to develop an integrated, mobile platform which detects and quantifies recombinant lentivirus in packaging cell supernatants.
Takara Bio unveils a new open-platform single-cell automation system compatible with industry-leading SMART-Seq technology for sensitive full-length transcriptome analysis at AGBT 2018
Date: February 12, 2018
Categories: Press release
Mountain View, CA—February 12, 2018—To advance the understanding of cell diversity and how that diversity impacts complex cellular functions including interactions with other cells and molecules, growth, and disease states, Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce the launch of the SMARTer ICELL8 cx System. The system will be presented to the scientific community at the Advances in Genome Biology and Technology (AGBT) General Meeting in Orlando FL, February 12–15, 2018.
Takara Bio USA, Inc., announces the use of the SMARTer ICELL8 Single-Cell System in clinical studies
Date: January 19, 2018
Categories: Press release
Mountain View, CA—January 19, 2018—Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that City of Hope has recently procured a SMARTer ICELL8 Single-Cell System to perform high-level studies involving high-throughput single-cell RNA-seq applications. This automated system provides a proven platform for unbiased isolation, evaluation, and selection of over a thousand single cells for downstream analyses, including next-generation sequencing (NGS), backed by recent citations in the literature.
We now offer products and services from Rubicon Genomics and WaferGen Bio-systems
Date: July 30, 2017
Categories: Announcement
Rubicon Genomics and WaferGen Bio-systems are now members of the Takara Bio Group. Going forward, all orders, inquiries, and technical support requests involving Rubicon and WaferGen products should be submitted directly to Takara Bio.
Takara Bio USA Holdings, Inc. completes acquisition of WaferGen Bio-systems, Inc.
Date: March 1, 2017
Categories: Press release
Mountain View, CA—March 1, 2017—Takara Bio USA Holdings, Inc. ("TBUSH") announced that it has completed the acquisition of WaferGen Bio-systems, Inc. ("WaferGen"), WaferGen has become a wholly owned subsidiary of TBUSH as of February 28, 2017 (US local time).
We are pleased to announce the completion of our merger with WaferGen Bio-systems
Date: February 28, 2017
Categories: Announcement
WaferGen Bio-systems, Inc., a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research, is now a member of the Takara Bio Group.
Takara Bio USA, Inc. and TeselaGen Biotechnology, Inc. release a powerful new primer tool for easy design of In‑Fusion Cloning experiments
Date: January 24, 2017
Categories: Press release
Mountain View and San Francisco, CA—January 24, 2017—Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the In-Fusion Cloning Primer Design Tool, powered by TeselaGen Biotechnology, Inc. software. In-Fusion Cloning, developed by TBUSA, is a unique method that seamlessly joins together linear fragments of DNA in a single, 15-minute reaction. The free, online primer design tool facilitates easy design and a smooth transition from planning to experimental work.
Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc.
Date: January 18, 2017
Categories: Press release
Mountain View, CA—January 18, 2017—Takara Bio USA Holdings, Inc. ("TBUSH") announced that it has completed the acquisition of Rubicon Genomics, Inc. ("Rubicon"). Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). The Takara Bio Group provides a wide range of life science products and services under the Takara, Clontech, and Cellartis brands that assist discovery, translational and clinical scientists in the advancement of their work. The Rubicon acquisition will allow the Takara Bio Group to augment and expand its worldwide commercial offerings in next generation sequencing (NGS) sample preparation and expand into new markets.
Takara Bio USA Holdings and Rubicon Genomics announce merger agreement
Date: December 15, 2016
Categories: Press release
Mountain View, CA and Ann Arbor, MI—December 15, 2016—Takara Bio USA Holdings, Inc. ("TBUSH") and Rubicon Genomics, Inc. ("Rubicon"), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon is a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency and speed of genomic analysis.
Takara Bio USA, Inc. to supply single-cell RNA-seq kit for the Allen Cell Types Database
Date: November 1, 2016
Categories: Press release
Mountain View, CA—November 1, 2016—Takara Bio USA, Inc., (TBUSA; formerly Clontech Laboratories, Inc.) announced today that its SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing has been selected for the development of gene expression profiles of individual brain cells as part of the Allen Cell Types Database, a public resource available from the Allen Institute for Brain Science. This database will extend knowledge about the various cell types in the brain, which in turn may shed light on how the healthy brain functions and what goes wrong in diseases such as autism, Alzheimer's and Parkinson's.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
